ReShape Lifesciences Inc.

Next-Level Bariatric Solutions at ReShape Lifesciences®. ReShape Lap-Band® 2.0 FLEX features an innovative tubing system for enhanced control over intra-band pressure. Offer your patients a more personalized, comfortable weight loss approach. Check out solutions for your patients: https://lnkd.in/gZ2TQb2g $RSLS #BariatricSurgery #Healthcare

Confronting Obesity Together. ReShape is passionate about tackling the global health crisis of #obesity. Our weight loss solutions are here to empower both patients and #healthcare providers. Discover how we're innovating in weight management: https://lnkd.in/gmRjQY9U $RSLS

ReShape Lap-Band® patient, Renata, shares her inspiring weight-loss journey: “If you’re considering the Lap-Band procedure, go for it. It’s the best thing I ever did for myself and my health. I never looked in the mirror because I got to the point where I didn’t recognize myself, but now I run to the beach and I can wear a bikini - I look at myself in the mirror and I’m proud of who I am now.” Learn about our solutions: https://lnkd.in/gmRjQY9U #BariatricSurgery #WeightLossSurgery #Healthcare Actual patient. The views and opinions expressed here are patient’s own. Patients’ experience and results may vary.

CEO Spotlight on the Obesity and Weight Loss Industry Landscape: "The weight loss industry continues to evolve, driven by factors such as increasing obesity rates and advancements in medical technology. #Bariatric surgery, including the ReShape Lap-Band® procedure, remains a viable option for individuals seeking significant weight loss. According to American Society for Metabolic and Bariatric Surgery (ASMBS) data, gastric bands continue to be a part of the surgical landscape, contributing to the overall growth of the market. The projected CAGR of 4.1% for the gastric band market during 2021-2031 reflects the ongoing demand for these procedures. Factors like growing awareness of obesity treatments, advancements in surgical techniques, and the increasing adoption of minimally invasive procedures are driving this growth,” commented Paul F. Hickey. “At ReShape Lifesciences®, we're committed to providing innovative solutions that address the needs of patients seeking effective and sustainable weight loss." Take a look at our transformative technologies here: https://lnkd.in/gmRjQY9U

The next generation of the ReShape Lap-Band® is here. Our next level FLEX Tubing is designed to modulate intra-band pressure to help provide a better eating experience. Discover new solutions for your patients: https://lnkd.in/gZ2TQb2g

At ReShape Lifesciences®, we're passionate about confronting the global health crisis head-on, providing safe & sustainable technology solutions for #obesity treatment. We strive to help patients and healthcare providers with our innovative technologies! #HealthTech #GlobalHealth Discover our solutions here: https://lnkd.in/gmRjQY9U

As Novo and Lilly Focus on a Few Big Markets, Sanofi Seeks Global Reach for Diabetes GLP-1 Drug. CEO Paul F. Hickey shares insight on Sanofi’s #GLP1 drug with journalist Patience Asanga in a new article via BioSpace: “Sanofi has a sophisticated global distribution system. It’s possible that Sanofi’s supply chain network could offer a substantial advantage if the company were to venture into the obesity market.” Read the article here: https://lnkd.in/gUS2ssmP #Obesity #Healthcare

ReShape is leading innovation in #obesity treatment. Our FDA-approved ReShape Lap-Band® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures. Learn more here: https://lnkd.in/gmRjQY9U #Healthcare #MedicalTechnology #Innovation #HealthTech

ReShape Lifesciences® is the premier #physician-led #weightloss and metabolic health-solutions company with an integrated portfolio of proven products and services that manage and treat #obesity and metabolic disease. Take a look at our transformative technologies here: https://lnkd.in/gmRjQY9U

Today at 4:30 PM ET, ReShape Lifesciences is hosting its Q2 2024 earnings conference call. Register for the webcast here: https://lnkd.in/g-QmP7bB